Real-world outcomes of teriflunomide in relapsing–remitting multiple sclerosis: a prospective cohort study

被引：0
|
作者：
Yao Zhang
Hexiang Yin
Dingding Zhang
Yan Xu
Bin Peng
Liying Cui
机构：
[1] Center of Multiple Sclerosis and Related Disorders,Department of Neurology
[2] Peking Union Medical College Hospital,Medical Research Center
[3] Peking Union Medical College Hospital,Neurosciences Center
[4] Peking Union Medical College & Chinese Academy of Medical Sciences,undefined
[5] Peking Union Medical College Hospital,undefined
[6] Peking Union Medical College & Chinese Academy of Medical Sciences,undefined
[7] Chinese Academy of Medical Sciences,undefined
来源：
Journal of Neurology | 2022年 / 269卷
关键词：
Multiple sclerosis; Teriflunomide; Real-world; No evidence of disease activity (NEDA); Efficacy; Safety;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4808 / 4816
页数：8
相关论文
共 50 条
  • [1] Real-world outcomes of teriflunomide in relapsing-remitting multiple sclerosis: a prospective cohort study
    Zhang, Yao
    Yin, Hexiang
    Zhang, Dingding
    Xu, Yan
    Peng, Bin
    Cui, Liying
    JOURNAL OF NEUROLOGY, 2022, 269 (09) : 4808 - 4816
  • [2] Real-world outcomes of teriflunomide in relapsing-remitting multiple sclerosis: a prospective cohort study
    Zhang, Y.
    Yin, H.
    Zhang, D.
    Xu, Y.
    Peng, B.
    Cui, L.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 888 - 889
  • [3] Effect of teriflunomide on epstein-barr virus shedding in relapsing-remitting multiple sclerosis patients: outcomes from a real-world cohort study
    Gold, J.
    Holden, D.
    Parratt, J.
    Yiannikas, C.
    Ahmad, R.
    Giovannoni, G.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 277 - 278
  • [4] Effect of teriflunomide on Epstein-Barr virus shedding in relapsing-remitting multiple sclerosis patients: Outcomes from a real-world pilot cohort study
    Gold, Julian
    Holden, David
    Parratt, John
    Yiannikas, Con
    Ahmad, Raghib
    Sedhom, Mamdouh
    Giovannoni, Gavin
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 68
  • [5] Effect of teriflunomide on Epstein-Barr virus shedding in relapsing-remitting multiple sclerosis patients: Outcomes from a real-world pilot cohort study
    Gold, Julian
    Holden, David
    Parratt, John
    Yiannikas, Con
    Ahmad, Raghib
    Sedhom, Mamdouh
    Giovannoni, Gavin
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 68
  • [6] Fatigue in teriflunomide-treated patients with relapsing remitting multiple sclerosis in the real-world Teri-FAST study
    de Seze, Jerome
    Devy, Richard
    Planque, Evelyne
    Delabrousse-Mayoux, Jean Philippe
    Vandhuick, Olivier
    Kabir, Marmar
    Gherib, Amel
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 47
  • [7] Fatigue in teriflunomide-treated patients with relapsing remitting multiple sclerosis in the real-world Teri-FAST Study
    de Seze, J.
    Devy, R.
    Planque, E.
    Delabrousse-Mayoux, J. P.
    Vandhuick, O.
    Kabir, M.
    Gherib, A.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 626 - 626
  • [8] A real-world cohort analysis of alemtuzumab outcomes in relapsing multiple sclerosis
    Herman, Jorge Acevedo
    Khalighinejad, Farnaz
    York, Katherine
    Radu, Irina
    Morales, Idanis Berrios
    Ionete, Carolina
    Hemond, Christopher C.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 47
  • [9] Real world efficacy and safety of teriflunomide in patients with relapsing-remitting multiple sclerosis
    Boz, C.
    Ozakbas, S.
    Terzi, M.
    Turkoglu, R.
    Akman, G.
    Efendi, H.
    Akcali, A.
    Tuncer, A.
    Yuceyar, N.
    Turan, O. F.
    Soysal, A.
    Koseoglu, M.
    Balci, B. P.
    Sevim, S.
    Altintas, A.
    Cilingir, V.
    Demirkiran, M.
    Kizilay, F.
    Altunrende, B.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 327 - 328
  • [10] Effectiveness and Safety of Teriflunomide in Relapsing–Remitting Multiple Sclerosis and Improvements in Quality of Life: Results from the Real-World TERICARE Study
    José E. Meca-Lallana
    José M. Prieto González
    Ana B. Caminero Rodríguez
    Javier Olascoaga Urtaza
    Ana M. Alonso
    Eduardo Durán Ferreras
    Raúl Espinosa
    Julio Dotor
    Mercedes Romera
    Adrián Ares Luque
    Domingo Pérez Ruiz
    Carmen Calles
    Miguel A. Hernández
    Miguel Hervás García
    Amelia Mendoza Rodríguez
    Yasmina Berdei Montero
    Nieves Téllez
    Nicolás Herrera Varó
    Javier Sotoca
    Silvia Presas-Rodríguez
    Luis A. Querol Gutierrez
    Mariona Hervás Pujol
    Jordi Batlle Nadal
    Gisela Martín Ozaeta
    Laura Gubieras Lillo
    Sergio Martínez Yélamos
    Lluís Ramió-Torrentà
    Javier Mallada Frechin
    Antonio Belenguer Benavides
    Francisco Gascón-Giménez
    Bonaventura Casanova
    Lamberto Landete Pascual
    Leticia Berenguer
    Laura Navarro
    Montserrat Gómez Gutierrez
    Carmen Durán
    Ana Rodríguez Regal
    Elena Álvarez
    Daniel A. García-Estévez
    Ana M. López Real
    Miguel A. Llaneza González
    María E. Marzo Sola
    José L. Sánchez-Menoyo
    Agustín Oterino
    Ramón Villaverde González
    Tamara Castillo-Triviño
    Amaya Álvarez de Arcaya
    Cristina Llarena
    Neurology and Therapy, 2023, 12 : 2177 - 2193
12345